Methods and apparatuses for coating a lesion

• US 8,518,105 B2
• Filed: 03/21/2007
• Issued: 08/27/2013
• Est. Priority Date: 03/24/2006
• Status: Expired due to Fees

• Current Assignee: Abbott Cardiovascular Systems Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Abbott Cardiovascular Systems Incorporated (Abbott Laboratories Incorporated)
• Inventors: Hossainy, Syed Faiyaz Ahmed, Trollsas, Mikael, Glauser, Thierry, Tang, Yiwen Eveleen, Michal, Eugene T.
• Primary Examiner(s): Cordero Garcia, Marcela M
• Application Number:
  US11/726,647
• Publication Number:
  US 20090005849A1
• Time in Patent Office: 2,351 Days
• Field of Search: None
• US Class Current: 623/1.39
• CPC Class Codes: A61L 2430/36 for embolization or occlusion, e.g. vaso-occlusive compositions or devices artificial blood vessels A61L27/507
• CPC Class Codes: A61L 31/043 Proteins; Polypeptides; Degradation products thereof
• CPC Class Codes: A61P 9/00 Drugs for disorders of the cardiovascular system

Abstract

A method and apparatus to treat regions of a vessel is described. A protein elastin-based polymer is released from the apparatus to coat the vessel lining as a primary therapy or an adjunct therapy with the delivery and deployment of a stent with or without drug coating. The protein elastin-based polymer may include a triblock structure having an elastin pentapeptide as the flanking block and a hydrophilic variant of the pentapeptide as the middle block. Both the flanking and middle blocks can be modified to change the structural and chemical properties of the polymer. In particular, the protein elastin based polymer is adapted to perform at least one of controlling release of a treatment agent, stimulating endothelial cell growth and stabilizing the vulnerable plaque to prevent rupture of the vulnerable plaque.

Claims

1. A method to treat a vessel comprising:

identifying a target region in a vessel comprising an artery;

delivering a protein elastin-based polymer solution to the target region in the vessel using a delivery system, the delivery system comprising a catheter and a porous balloon; and

coating the target region with the protein elastin-based polymer solution, wherein the porous balloon evenly distributes the solution onto walls of the artery, and wherein the porous balloon includes pores along the entire length of the porous balloon that touches the walls of the artery.

2. The method of claim 1 wherein an area in the vessel adjacent to the target region of the vessel is also coated with the protein elastin-based polymer.

3. The method of claim 1 wherein the protein elastin-based polymer forms an elastic coating on the vessel wall after the vessel wall is coated with the protein elastin-based polymer solution.

4. The method of claim 3 wherein the elastic coating has a property that stabilizes the target region.

5. The method of claim 3 wherein the elastic coating has a property that reinforces the target region.

6. The method of claim 3 wherein the elastic coating has a property that protects the target region.

7. The method of claim 3 wherein the elastic coating further comprises a treatment agent.

8. The method of claim 7 wherein the elastic coating is capable of controlled release of the treatment agent for absorption by the vessel.

9. The method of claim 1 wherein the protein elastin-based polymer further comprises triblock structure consisting of two flanking blocks and a middle block wherein each block further comprises at least one component.

10. The method of claim 9 wherein a component within each block within the triblock structure is selected from a group consisting of an amino acid, an amino acid sequence or a monomer.

11. The method of claim 9 wherein the triblock structure further comprises an elastin pentapeptide as a flanking block to provide a viscoelastic property.

12. The method of claim 9 wherein a variant elastin pentapeptide of the flanking block is used as a middle block to provide backbone support.

13. The method of claim 9 wherein a variant elastin pentapeptide of the flanking block is used as a middle block to provide biocompatibility.

14. The method of claim 9 wherein a variant elastin pentapeptide of the flanking block is used as a middle block to provide a drug delivery property.

16. The method of claim 10 wherein one or more pendant groups are attached to at least one component of the protein triblock structure.

17. The method of claim 16 wherein the pendant group is selected from a group consisting of phosphorylcholine (PC) and polyethylene glycol (PEG).

18. The method of claim 17 to reinforce a fibrous cap and increase reendothelialization of vessel arterial lining.

19. The method of claim 16 wherein the pendant group is selected from the group consisting of an acrylate, vinyl sulfones, vinyl ethers, allyl ethers, maleimides, and activated esters.

20. The method of claim 16 wherein the pendant group is attached to the middle block.

21. The method of claim 20 wherein the pendant group is selected from the group consisting of sulfonic acids, sulfonic salts, sulfonates, amines and amides.

22. The method of claim 20 wherein the pendant group is a peptide sequence.

23. The method of claim 9 wherein a peptide sequence acts as the middle block by itself.

24. The method of claim 22 or 23 wherein the peptide sequence is RAD16-II.

25. The method of claim 22 or 23 wherein the peptide sequence is RGD.

26. The method of claim 22 or 23 wherein the peptide sequence is SIKAV [SEQ ID NO. 7].

27. The method of claim 22 or 23 wherein the peptide sequence is YIGSRG [SEQ ID NO. 8].

29. The method of claim 9 wherein the protein triblock polymer is delivered below the LCST of the polymer to form a coating on the vessel wall.

30. The method of claim 9 wherein the protein triblock polymer comprises a two component solution.

31. The method of claim 30 wherein a first component is a triblock polymer and a second component comprises a cross-linking compound that are mixed in situ to result in a coating on the vessel wall.

32. The method of claim 31 wherein the first component and the second component of the two component solution are delivered substantially simultaneously.

33. The method of claim 31 wherein the cross-linking compound is a di- or poly-thiol functionalized compound.

34. The method of claim 30 wherein a second component solution is of a different pH than the first component solution.

35. The method of claim 30 wherein a second component solution is of an osmolarity different than that of the first component solution.

36. The method of claim 7 wherein the treatment agent further comprises at least one of a member selected from the group consisting of agents which promote endothelialization, agents which promote healing, and agents which remove lipid from plaque.

37. The method of claim 1 wherein the target region further comprises at least one of a denuded endothelial region, a stenotic region treated or not treated for stenosis, an inflamed vessel segment, a region anticipated to be stenotic or inflammatory, and a region with a vulnerable plaque.

38. The method of claim 37 wherein the protein elastin-based polymer reinforces and stabilizes the fibrous cap of a vulnerable plaque to prevent rupture of the fibrous cap.

39. The method of claim 1 wherein the delivery system comprises an inflatable balloon catheter wherein the protein elastin-based polymer is delivered by inflating the porous balloon at the target lesion.

40. The method of claim 39 wherein inflatable balloon is a complementary therapy to a drug eluting stent.

41. The method of claim 1 wherein the protein elastin-based polymer inside the delivery system is at a temperature that is below the temperature of the blood outside the delivery catheter system.

42. The method of claim 41 wherein the delivery system is made of a thermoelectric material or an insulating material.

43. The method of claim 1, wherein delivering a solution comprises delivering at a temperature between 1°

C. and 10°

C.

44. The method of claim 1, wherein the protein elastin-based polymer solution comprises a ten percent aqueous solution.

47. The method of claim 1, further comprising delivering the protein elastin-based polymer solution to a vessel comprising an artery to repair the artery.

15. A method to treat a vessel comprising:

identifying a target region in a vessel comprising an artery;

delivering a protein elastin-based polymer solution to the target region in the vessel using a delivery system, the delivery system comprising a catheter and a porous balloon, wherein the porous balloon includes pores along the entire length of the porous balloon that touches an inner wall of the artery; and

coating the target region with the protein elastin-based polymer solution, wherein the protein elastin-based polymer further comprises triblock structure consisting of two flanking blocks and a middle block wherein each block further comprises at least one component, and wherein the protein triblock structure is of the general formula (VPGVG)₄(VPGXG_n(VPGVG)₄), wherein X is selected from the group consisting of Lysine [SEQ ID NO. 60], arginine [SEQ ID NO. 12], glutamic acid [SEQ ID NO. 13], and aspartic acid [SEQ ID NO. 14].

28. A method to treat a vessel comprising:

identifying a target region in a vessel comprising an artery;

delivering a protein elastin-based polymer solution to the target region in the vessel using a delivery system, the delivery system comprising a catheter and a porous balloon, wherein the porous balloon includes pores along the entire length of the porous balloon that touches an inner wall of the artery; and

coating the target region with the protein elastin-based polymer solution, wherein the protein elastin-based polymer further comprises triblock structure consisting of two flanking blocks and a middle block wherein each block further comprises at least one component, and wherein the triblock protein polymer is of the general formula (VPGVG)₄(X) [SEQ ID NOS. 4-5], where X is selected from a group consisting of polyethylene glycol (PEG), poly(hydroxyethyl methacrylate) (polyHEMA), poly(vinyl pyrrolidinone) (PVP), and collagen.

45. A method to treat a vessel comprising:

identifying a target region in a vessel;

delivering a protein elastin-based polymer solution to the target region in the vessel using a delivery system, wherein the delivery system comprises a porous balloon that includes pores along the entire length of the porous balloon that touches an inner wall of the artery, wherein the protein elastin-based polymer solution comprises a protein elastin-based polymer comprising a triblock structure including two flanking blocks and a middle block wherein a component within each block is selected from the group consisting of an amino acid, an amino acid sequence and a monomer and the middle block comprises a pendant group comprising a peptide sequence of YIGSRG [SEQ ID NO. 8]; and

coating the target region with the protein elastin-based polymer solution.

46. A method to treat a vessel comprising:

identifying a target region in a vessel;

delivering a protein elastin-based polymer solution to the target region in the vessel using a delivery system, wherein the delivery system comprises a porous balloon that includes pores along the entire length of the porous balloon that touches an inner wall of the artery, wherein the protein elastin-based polymer solution comprises a protein elastin-based polymer comprises a triblock structure including two flanking blocks and a middle block wherein a component within each flanking block is selected from the group consisting of an amino acid, an amino acid sequence and a monomer and the middle block comprises a peptide sequence of YIGSRG [SEQ ID NO. 8]; and

coating the target region with the protein elastin-based polymer solution.

48. A method to treat a vessel comprising:

identifying a target region in a vessel comprising an artery;

delivering a protein elastin-based polymer solution to the target region in the vessel using a delivery system, the delivery system comprising a catheter and a porous balloon; and

coating the target region with the protein elastin-based polymer solution, wherein the porous balloon forces the solution evenly into, and protectively coats the entire surface of a length and circumference of the inner wall of the artery, and wherein the porous balloon includes pores along the entire length of the porous balloon that touches the inner wall of the artery.

49. The method of claim 48, further comprising delivering the protein elastin-based polymer to a vessel comprising an artery to repair the artery.

50. A method to treat a vessel comprising:

identifying a target region in a vessel comprising an artery;

delivering a protein elastin-based polymer solution to the target region in the vessel using a delivery system, the delivery system comprising a catheter and a porous balloon; and

coating the target region with the protein elastin-based polymer solution, wherein the porous balloon forces the solution evenly into, and protectively coats the entire surface of a length and circumference of the inner wall of the artery, wherein the porous balloon is rotated while forcing the solution evenly into the length and circumference, in order to protectively coat the entire surface of the length and circumference.